Serving
Overlooked Patients
Azurity specializes in providing innovative, high-quality products that address the specific needs of patients with underserved conditions.
Serving
Overlooked Patients
Azurity specializes in providing innovative, high-quality products that address the specific needs of patients with underserved conditions.
Serving
Overlooked Patients
Azurity specializes in providing innovative, high-quality products that address the specific needs of patients with underserved conditions.
Medicine that’s RIGHT FOR OUR PATIENTS.
Azurity’s products have benefited millions of patients whose needs are not served by other commercially available therapies.
Azurity currently offers a comprehensive product portfolio that serves multiple therapeutic areas, with more on the way!
FDA-APPROVED & NON-APPROVED PRODUCTS
A growing portfolio of products designed to fulfill unmet needs of patients.
NON-FDA APPROVED FIRST® COMPOUNDING KITS
A family of prescription compounding kits designed as an alternative to conventional dosage forms.
Pharmacist to Pharmacist
Challenged by the ever-changing compounding landscape? Don’t be. Click to learn How FIRST® Kits Help Pharmacists – professionals like you – facilitate their obligations under 503A and USP <795>.
Visit our resource center now to learn more
Compounding made convenient & consistent.
Pharmacist to Pharmacist
Challenged by the ever-changing compounding landscape? Don’t be.
Click to learn How FIRST® Kits Help Pharmacists – professionals like you – facilitate their obligations under 503A and USP <795>.
Visit our resource center now to learn more
Compounding made convenient & consistent.
News & Events
AZURITY PHARMACEUTICALS, INC. ANNOUNCES U.S. AVAILABILITY OF ZONISADE™ (zonisamide oral suspension)
MEDIA ALERT: Woburn, Mass. – October 12, 2022 – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing innovative products to serve the specific needs of overlooked…
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF KONVOMEP™ (omeprazole and sodium bicarbonate for oral suspension)
Woburn, Mass. – September 2, 2022 – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing innovative dose-forms and formulations of products to serve the needs of overlooked…
